Transcribed
Virginia Focus - Medicare & Alzheimers Meds
Oct 27, 2023 ·
29m 30s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Virginia Focus - Medicare & Alzheimers Meds
This is an automatically generated transcript. Please note that complete accuracy is not guaranteed.
Description
More than six million Americans are currently living with Alzheimer's disease and by 2050, that number is expected to skyrocket to 13 million. The FDA approved two new treatments that...
show more
More than six million Americans are currently living with Alzheimer's disease and by 2050, that number is expected to skyrocket to 13 million. The FDA approved two new treatments that slow the progression of the disease, but the Centers for Medicare and Medicaid Services, also known as CMS, is setting a dangerous precedent by requiring consent from patients in a way that's never been demanded before. Now many doctors, elected leaders, and families are afraid patients will face health disparities and that the move could be expanded to limit access to other medications. Let's hear more from the Chairman of the Partnership to Fight Chronic Disease and Chairman of Health Policy and Management at Emory University, Dr. Kenneth Thorpe.
show less
Information
| Author | 640 WGST (WGST-AM) |
| Organization | iHeartRadio |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
